AbbVie's Venetoclax patent bid in India fails after invention ruled obvious
AbbVie Ireland has lost its bid for an Indian patent for the cancer drug Venetoclax after the Controller of Patent ruled the claimed invention obvious. AbbVie Ireland has seen its patent application...To view the full article, register now.
Already a subscriber? Click here to view full article